Peplin announces positive results of skin cancer trial
Key points
- Peplin Limited today announced positive results from its Australian phase IIa clinical trial of its proprietary drug PEP005 Topical in superficial forms of basal cell carcinoma (sBCC) the most common form of skin cancer.
- The phase IIa clinical trial achieved its objectives.
- Managing Director & CEO Michael Aldridge said these positive results were a significant milestone for the company and of great interest to people with skin cancers in Australia and worldwide.
- "The results of this Australian clinical trial exceeded our expectations," Mr Aldridge said.
Peplin Limited today announced positive results from its Australian phase IIa clinical trial of its proprietary drug PEP005 Topical in superficial forms of basal cell carcinoma (sBCC) the most common form of skin cancer.
The phase IIa clinical trial achieved its objectives. Just two applications of PEP005 Topical (0.05%) gel on two consecutive days cleared 71% of sBCC tumours. This result was statistically significant (p=0.02). In addition PEP005 Topical gel had a favourable safety profile and was well tolerated. The majority of local skin responses reported were graded mild or moderate.
Managing Director & CEO Michael Aldridge said these positive results were a significant milestone for the company and of great interest to people with skin cancers in Australia and worldwide.
"The results of this Australian clinical trial exceeded our expectations," Mr Aldridge said.
"While we achieved the primary purpose of the trial which was to establish the safety of the drug in treating non-melanoma skin cancers, we have shown that two consecutive days of treatment with PEP005 Topical gel can clear nearly three quarters of basal cell carcinomas, the most common form of skin cancer.
"Our next steps will be to undertake larger trials in Australia and the US starting later this year in order to make application to obtain regulatory approval to market the product as quickly as possible."
http://www.peplin.com
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsScientists find new way to combat drug resistance in skin cancer
RAPID RESISTANCE to vemurafenib - a treatment for a type of advanced melanoma, the deadliest form of skin cancer - could be prevented by blocking a druggable family of proteins, according to research* published in…
23 May 2014
NewsFalse-positive mammograms have limited effect on anxiety
Women whose mammograms suggest possible breast cancer that is eventually ruled out experience slightly increased anxiety, but that doesn't necessarily affect their overall health, according to a new study. What's more,…
22 April 2014
NewsOnline Course Improves Physicians Skill Level for Detecting Skin Cancer
Primary care physicians who took an online training course about skin cancer detection significantly improved their skill to properly diagnose and manage benign and malignant lesions, according to a national study from…
